加载中
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
最新数据
JP¥753
+JP¥9.00 · +1.21%
盘中时间采用JST。市场数据可能有所延迟。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日内区间
当前JP¥753
52周区间
当前JP¥753
盘中时间采用JST。市场数据可能有所延迟。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日内区间
当前JP¥753
52周区间
当前JP¥753
营业利润
净利润
| 项目（JPY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | — | — | 10亿 JPY | — | — |
| 销货成本 | — | — | 9000万 JPY | — | 680.3万 JPY |
| 毛利 | — | — | 9.1亿 JPY | — | −680.3万 JPY |
| 研究与开发 | — | 4.52亿 JPY | — | 1.64亿 JPY | 1.35亿 JPY |
| 销售、一般及管理费用 | 9.16亿 JPY | 3.79亿 JPY | −1000 JPY | 1.69亿 JPY | 6797.1万 JPY |
| 营业费用 | 9.16亿 JPY | 8.36亿 JPY | 5.44亿 JPY | 3.54亿 JPY | 2.13亿 JPY |
| 利息收入 | 300.3万 JPY | 26.5万 JPY | 1.6万 JPY | 7000 JPY | 1000 JPY |
| 利息支出 | 731.1万 JPY | — | 1184.9万 JPY | — | — |
| 折旧和摊销 | — | — | 1000 JPY | — | 680.3万 JPY |
| 营业利润 | −9.16亿 JPY | −8.36亿 JPY | 3.66亿 JPY | −3.54亿 JPY | −2.19亿 JPY |
| 净利润 | −9.93亿 JPY | −8.46亿 JPY | 2.6亿 JPY | −3.92亿 JPY | −2.29亿 JPY |
公司数据更新于 2026年10月11日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
